Precision Medicine Group

Employee Size

1,001-5,000

Organization Type

Privately Held

Headquarters

Bethesda, MD

Founded in 2012, Precision Medicine Group is a global life-sciences services company built to change how new drugs reach patients. Its 3,500 experts support pharmaceutical and biotechnology clients across clinical development and commercialization, using data and technology to address complex healthcare challenges.

• PharmaronFounded in 2004, Pharmaron is a global life-sciences service company with more than 25,000 employees working across China, the United States and the United Kingdom. It is known for carrying drug programs from discovery through development and manufacturing, serving pharmaceutical, biotechnology and medical-device companies along the way.EXTON, PA
• Clinigen GroupClinigen Group helps pharmaceutical and biotechnology companies move medicines through clinical development and into patients, combining clinical-trial supply management with managed access and global partnering. With regional teams across North America, Europe, Africa, Japan and Asia Pacific, the company has accelerated access to medicines in more than 130 countries. Clinigen also supplies hard-to-find and unlicensed medicines through its Clinigen Direct platform, drawing on more than 30 years of experience in that work.FARGO, ND
• Sharp ServicesWith a heritage spanning more than 70 years, Sharp Services is a pharmaceutical contract development and manufacturing company with more than 2,500 employees across four countries. It helps pharmaceutical and biopharmaceutical clients bring therapies from early clinical development through commercial launch, with a global GMP network and a quality system built around patient safety and regulatory compliance.ALLENTOWN, PA
• IG
  Indivumed GmbHFounded in 2002 by surgical oncologist Prof. Dr. Hartmut Juhl, Hamburg-based Indivumed GmbH is a biotech company developing precision-oncology therapeutics from patient-derived cancer data. Its clinically grounded R&D combines more than 20 years of standardized tumor-sample collection with proprietary multi-omics analysis and patient-derived tumor models to identify and validate drug targets. A global clinical network spanning North America, Europe, and Asia gives the company a broad, patient-native view of cancer biology.FREDERICK, MD